| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 24 |
| 1 | ESOMEPRAZOLE MAGNESIUM | 24 |
| 2 | ADALIMUMAB | 22 |
| 3 | OMEPRAZOLE MAGNESIUM | 20 |
| 4 | DEXLANSOPRAZOLE | 17 |
| 5 | MONTELUKAST SODIUM | 17 |
| 6 | CICLESONIDE | 16 |
| 7 | MEPOLIZUMAB | 15 |
| 8 | ERGOCALCIFEROL | 13 |
| 9 | RANITIDINE HYDROCHLORIDE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-ARGININE | 1 | 0.0028 |
| 1 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 1 | 0.0027 |
| 2 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 1 | 0.0027 |
| 3 | CICLESONIDE | 16 | 0.0012 |
| 4 | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | 1 | 0.0008 |
| 5 | BRODALUMAB | 1 | 0.0005 |
| 6 | ERGOCALCIFEROL | 13 | 0.0004 |
| 7 | DEXLANSOPRAZOLE | 17 | 0.0004 |
| 8 | AZILSARTAN KAMEDOXOMIL | 1 | 0.0003 |
| 9 | CILOSTAZOL | 2 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 36 |
| 1 | Corticosteroid [EPC] | 22 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 3 | Interleukin-5 Antagonist [EPC] | 15 |
| 4 | Provitamin D2 Compound [EPC] | 13 |
| 5 | Benzodiazepine [EPC] | 12 |
| 6 | Loop Diuretic [EPC] | 12 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 12 |
| 8 | Thiazide Diuretic [EPC] | 10 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 15 | 0.0218 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 5 | GLP-2 Analog [EPC] | 3 | 0.0002 |
| 6 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 7 | Soluble Guanylate Cyclase Stimulator [EPC] | 3 | 0.0001 |
| 8 | Aluminum Complex [EPC] | 2 | 0.0001 |
| 9 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |